Clinical Trial Update: A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

AZD8205 is being studied in a Phase I/IIa trial as a single agent or in combination for advanced/metastatic solid tumors. Recruitment is ongoing across multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Breast Cancer
• Endometrial Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• AZD8205

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer, Biliary Tract Carcinoma | Phase 1, Phase 2 | Status: RECRUITING